These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 21810280

  • 1. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP, Csurhes PA, Pfluger CM, Burrows SR.
    BMC Neurol; 2011 Aug 03; 11():95. PubMed ID: 21810280
    [Abstract] [Full Text] [Related]

  • 2. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR.
    J Neurol Neurosurg Psychiatry; 2009 May 03; 80(5):498-505. PubMed ID: 19015225
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F.
    J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578295
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients.
    Jørgensen PB, Livbjerg AH, Hansen HJ, Petersen T, Höllsberg P.
    PLoS One; 2012 Dec 15; 7(9):e46120. PubMed ID: 23049954
    [Abstract] [Full Text] [Related]

  • 5. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.
    Brain; 2008 Jul 15; 131(Pt 7):1712-21. PubMed ID: 18550621
    [Abstract] [Full Text] [Related]

  • 6. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
    Jilek S, Schluep M, Harari A, Canales M, Lysandropoulos A, Zekeridou A, Pantaleo G, Du Pasquier RA.
    J Immunol; 2012 May 01; 188(9):4671-80. PubMed ID: 22461701
    [Abstract] [Full Text] [Related]

  • 7. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
    Veroni C, Aloisi F.
    Front Immunol; 2021 May 01; 12():665718. PubMed ID: 34305896
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
    Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W.
    Proc Natl Acad Sci U S A; 2016 Oct 18; 113(42):E6467-E6475. PubMed ID: 27698133
    [Abstract] [Full Text] [Related]

  • 9. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GM.
    Mult Scler; 2016 Mar 18; 22(3):279-91. PubMed ID: 26041797
    [Abstract] [Full Text] [Related]

  • 10. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L.
    PLoS Pathog; 2013 Mar 18; 9(4):e1003220. PubMed ID: 23592979
    [Abstract] [Full Text] [Related]

  • 11. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.
    Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J.
    Eur J Immunol; 2014 Nov 18; 44(11):3439-52. PubMed ID: 25103993
    [Abstract] [Full Text] [Related]

  • 12. Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
    Pender MP, Csurhes PA, Pfluger CM, Burrows SR.
    Mult Scler; 2014 Dec 18; 20(14):1825-32. PubMed ID: 24842963
    [Abstract] [Full Text] [Related]

  • 13. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P, Hansen HJ, Haahr S.
    Clin Exp Immunol; 2003 Apr 18; 132(1):137-43. PubMed ID: 12653848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
    Fogg MH, Wirth LJ, Posner M, Wang F.
    Proc Natl Acad Sci U S A; 2009 Mar 03; 106(9):3318-23. PubMed ID: 19211798
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
    Zdimerova H, Murer A, Engelmann C, Raykova A, Deng Y, Gujer C, Rühl J, McHugh D, Caduff N, Naghavian R, Pezzino G, Capaul R, Zbinden A, Ferlazzo G, Lünemann JD, Martin R, Chatterjee B, Münz C.
    Eur J Immunol; 2021 Jan 03; 51(1):64-75. PubMed ID: 32949466
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
    Cárdenas D, Vélez G, Orfao A, Herrera MV, Solano J, Olaya M, Uribe AM, Saavedra C, Duarte M, Rodríguez M, López M, Fiorentino S, Quijano S.
    Clin Exp Immunol; 2015 Nov 03; 182(2):173-83. PubMed ID: 26174440
    [Abstract] [Full Text] [Related]

  • 19. Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.
    Keane JT, Afrasiabi A, Schibeci SD, Fewings N, Parnell GP, Swaminathan S, Booth DR.
    Front Immunol; 2021 Nov 03; 12():732694. PubMed ID: 34566997
    [Abstract] [Full Text] [Related]

  • 20. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.
    J Rheumatol; 2005 Feb 03; 32(2):239-51. PubMed ID: 15693083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.